Anti-kit antibodies and uses thereof
AssigneeCelldex Therapeutics, Inc.
InventorsYaron Hadari, Elizabeth M. Mandel-Bausch, Susanne Radke, Joseph Schlessinger, Yoshihisa Suzuki
Life of this patent
Estimating the term…
Loading patent…
AssigneeCelldex Therapeutics, Inc.
InventorsYaron Hadari, Elizabeth M. Mandel-Bausch, Susanne Radke, Joseph Schlessinger, Yoshihisa Suzuki
Estimating the term…
Provided herein, in one aspect, are antibodies that immunospecifically bind to a human KIT antigen comprising the fourth and/or fifth extracellular Ig-like domains (that is, D4 and/or D5 domains), polynucleotides comprising nucleotide sequences encoding such antibodies, and expression vectors and host cells for producing such antibodies. The antibodies can inhibit KIT activity, such as ligand-induced receptor phosphorylation. Also provided herein are kits and pharmaceutical compositions comprising antibodies that specifically bind to a KIT antigen, as well as methods of treating or managing a KIT-mediated disorder or disease and methods of diagnosing a KIT-mediated disorder or disease using the antibodies described herein.
An antibody, which immunospecifically binds to a D4/D5 region of human KIT (SEQ ID NO:
An antibody, which immunospecifically binds to a D4/D5 region of human KIT (SEQ ID NO:
An antibody, which immunospecifically binds to a D4/D5 region of human KIT (SEQ ID NO:
An antibody, which immunospecifically binds to a D4/D5 region of human KIT (SEQ ID NO:
An antibody, which specifically binds to an epitope within a D4/D5 region of human KIT (SEQ ID NO:
An antibody, which specifically binds to an epitope within a D4/D5 region of human KIT (SEQ ID NO:
Dependencies are inferred from the claim text.